Ablation of IL-17A abrogates progression of spontaneous intestinal tumorigenesis
The intrinsic role of endogenous IL-17A in spontaneous intestinal tumorigenesis has not been addressed previously to our knowledge. Ablation of IL-17A significantly reduced tumor development in mice bearing a heterozygote mutation in the adenomatous polyposis coli (APC) gene (ApcMin/⁺ mice). There w...
Saved in:
Published in | Proceedings of the National Academy of Sciences - PNAS Vol. 107; no. 12; pp. 5540 - 5544 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
National Academy of Sciences
23.03.2010
National Acad Sciences |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The intrinsic role of endogenous IL-17A in spontaneous intestinal tumorigenesis has not been addressed previously to our knowledge. Ablation of IL-17A significantly reduced tumor development in mice bearing a heterozygote mutation in the adenomatous polyposis coli (APC) gene (ApcMin/⁺ mice). There was also a decrease in inflammatory cytokines and proinflammatory mediators, reduced infiltration of lymphocytes including T cells, and preservation of intestinal architecture and the presence of APC protein in intestinal epithelial cells. Interestingly, IL-17A ablation also corrected immunological abnormalities such as splenomegaly and thymic atrophy in ApcMin/⁺ mice. CD4 T cells from ApcMin/⁺ mice showed hyperproliferative potential in vitro and in vivo and increased levels of IL-17A and IL-10. The effector CD4 T cells from ApcMin/⁺ mice were more resistant to regulatory T cell-mediated suppression. Finally, these CD4 T cells induced colitis in immunodeficient mice upon adoptive transfer, whereas the ablation of IL-17A in CD4 T cells in ApcMin/⁺ mice completely abolished this pathogenic potential in vivo. Taken together, our results show that CD4 T cell-derived IL-17A promotes spontaneous intestinal tumorigenesis with altered functions of CD4 T cells in ApcMin/⁺ mice. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Author contributions: W.J.C. and A.L.M.B. designed research; W.J.C., T.G., and O.H. performed research; W.J.C., D.Z., L.M.H., and A.L.M.B. analyzed data; and W.J.C. and A.L.M.B. wrote the paper. Edited* by Richard A, Flavell, Yale University School of Medicine, Howard Hughes Medical Institute, New Haven, CT, and approved February 9, 2010 (received for review November 3, 2009) |
ISSN: | 0027-8424 1091-6490 |
DOI: | 10.1073/pnas.0912675107 |